These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8912902)
21. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment. Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898 [TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease. Woodhouse A; Vickers JC; Dickson TC Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832 [TBL] [Abstract][Full Text] [Related]
23. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957 [TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356 [TBL] [Abstract][Full Text] [Related]
25. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes. Hua X; Lei M; Ding J; Han Q; Hu G; Xiao M Exp Neurol; 2008 Apr; 210(2):709-18. PubMed ID: 18289535 [TBL] [Abstract][Full Text] [Related]
26. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems. Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997 [TBL] [Abstract][Full Text] [Related]
27. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity. Caraci F; Chisari M; Frasca G; Canonico PL; Battaglia A; Calafiore M; Battaglia G; Bosco P; Nicoletti F; Copani A; Sortino MA Brain Res; 2005 Jun; 1047(1):30-7. PubMed ID: 15882840 [TBL] [Abstract][Full Text] [Related]
28. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related]
29. The combination of silver techniques for studying the pathology of Alzheimer's disease. Tsamis K; Mytilinaios D; Njau SN; Psaroulis D; Mavroudis J; Costa V; Baloyannis SJ Int J Neurosci; 2008 Feb; 118(2):257-66. PubMed ID: 18205081 [TBL] [Abstract][Full Text] [Related]
30. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385 [TBL] [Abstract][Full Text] [Related]
31. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468 [TBL] [Abstract][Full Text] [Related]
32. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Liu M; Sun A; Shin EJ; Liu X; Kim SG; Runyons CR; Markesbery W; Kim HC; Bing G Eur J Neurosci; 2006 Apr; 23(8):2027-34. PubMed ID: 16630050 [TBL] [Abstract][Full Text] [Related]
34. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease. Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767 [TBL] [Abstract][Full Text] [Related]
35. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease. Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of regeneration in Alzheimer's disease brain. Uchida Y Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S158-68. PubMed ID: 20590831 [TBL] [Abstract][Full Text] [Related]
37. Beta-amyloid-induced reactive astrocytes display altered ability to support dendrite and axon growth from mouse cerebral cortical neurons in vitro. Monnerie H; Esquenazi S; Shashidhara S; Le Roux PD Neurol Res; 2005 Jul; 27(5):525-32. PubMed ID: 15978180 [TBL] [Abstract][Full Text] [Related]
38. Neuronal response to physical injury and its relationship to the pathology of Alzheimer's disease. King CE; Adlard PA; Dickson TC; Vickers JC Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):548-52. PubMed ID: 10874516 [TBL] [Abstract][Full Text] [Related]
39. Autolysosomes in Alzheimer's disease and their possible role in its pathogenesis. An ultrastructural study. Soustek Z Zentralbl Pathol; 1994 Jul; 140(2):143-8. PubMed ID: 7947619 [TBL] [Abstract][Full Text] [Related]